chevrons

Back to Previous Page

VPBank (VPB VN) – H1 2025 – Profits Surge on Credit Boom

Summary of H1 2025 results and outlook of VPBank (VPB VN)

  • Net income surged 22.8% y/y, fueled by accelerated credit expansion and continued sharp enhancement in asset quality. Total credit grew 30.3% y/y, driven by strong demand across diversified corporate sectors, as well as various retail segments including consumption, mortgages, and margin lending. Net interest margin (NIM) contracted by 53bps in line with the sector trend amid a sustained low-interest rate environment; however, the decline was more moderate thanks to VPB’s strong funding position, supported by securing large offshore fundings and robust customer deposit mobilization. Net fee income (NFI) declined 26.1% y/y, primarily due to the regulatory reclassification of Letter of Credit fees as interest income, while other fee segments saw continued growth, most notably bancassurance. With the bank returning to strong business expansion post-restructuring, operating expenses rose 21.8% y/y; however, the cost-to-income ratio (CIR) remained at a market-leading 25.8%. Asset quality improvements were another key driver of profitability, with easing credit costs at both FE Credit (FEC) and the parent bank leading to a 10.5% y/y decline in provision expenses. Notably, the consolidated NPL and group 2 loan ratios dropped sharply in H1, signaling improved asset quality and limited formation of new bad debts.
  • Strategic access to international capital markets enhances VPB’s capacity to sustain superior growth while positioning it favorably in terms of funding costs. Alongside strong deposit growth, offshore funding is becoming a major source fueling the bank’s expansion. Following its record-breaking USD1.0bn syndicated loan in May, VPB secured an additional USD350mn syndicated loan at the end of July, with both deals led by its strategic investor Sumitomo Mitsui Banking Corporation (SMBC). These transactions bring the bank’s YTD offshore funding mobilization to nearly USD1.6bn, strengthening its liquidity position and potentially lowering funding costs going forward should USD interest rates begin to decline.
  • In the second half, we expect credit growth to continue accelerating, while NIM stabilizes at the moderate level set in Q1. Expansion will likely be driven by mortgage lending—particularly for affordable housing—alongside rising consumer finance demand amid the broader economic recovery. Lending to industrial developers and construction firms is also expected to gain momentum. However, the low-interest rate environment is likely to persist, keeping NIM at a stable but moderate level.

Interested in VPB? Click here to read more of our previous analysis on VPB’s quarterly earnings.

Company ratings and target prices are accessible for clients only.

If you are interested in getting full access to our paid Primary Research Materials feel free to get in touch with us at your convenience.

Our team is actively covering 50 companies in the listed Vietnamese equity space for our clients.

Photo image credit: VPBank

Related News & Insights
Find out more navigation_button
news

Summary of FY 2025 results and outlook of Quang Ngai Sugar JSC (QNS VN) 2025 revenue rose 3.2%, as strong growth in plant-based beverages (in which 93% is soya milk), offset weaker sugar performance. Revenue from plant-based beverages increased 15.1% y/y, driven by a 3.5% rise in sales volume, a 4.0% increase in average selling […]

Read Newsarrow
news

Summary of FY 2025 results and outlook of Phuoc Hoa Rubber JSC (PHR VN) PHR operates two core business segments: (1) rubber plantation and natural rubber sales, and (2) conversion of plantation land for IP development. In 2025, net profit rose by 10.2% y/y to VND532 bn, supported by contributions from both segments. The IP […]

Read Newsarrow
news

Summary of FY 2025 results and outlook of DHG Pharmaceutical JSC (DHG VN) Effective execution amid structural changes in the pharmacy channel. The segment underwent a period of notable transition in 2025, driven by new tax and e-invoicing requirements, alongside stricter enforcement against counterfeit drugs. These changes disrupted operations at traditional pharmacies—DHG’s core customer base. […]

Read Newsarrow
Find out more navigation_button